{"paper_id":"bb2b3852-3ad5-44e7-806a-30bd2d8384e6","body_text":"Abstract\nCancer-related pelvic pain is a disorder that can be difficult to evaluate and treat. The causes can be multifactorial, and treatment often requires a multidisciplinary approach. It is important to obtain a thorough history and physical to discover the cause or causes of the patient’s pain. Treatment may involve multiple physicians, physical therapists, and psychologists.\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nApte G, et al. Chronic female pelvic pain—part 1: clinical pathoanatomy and examination of the pelvic region. Pain Pract. 2012;12(2):88–110.\nStein SL. Chronic pelvic pain. Gastroenterol Clin N Am. 2013;42(4):785–800.\nReiter R. Evidence-based management of chronic pelvic pain. Clin Obstet Gynecol. 1998;41(2):422–35.\nTu FF, As-Sanie S, Steege JF. Musculoskeletal causes of chronic pelvic pain: a systematic review of diagnosis: part I. Obstet Gynecol Surv. 2005;60(6):379–85.\nMathias SD, et al. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol. 1996;87(3):321–7.\nHowlader N, et al. SEER cancer statistics review, 1975–2012. Bethesda: National Cancer Institute; 2015.\nPrather H, et al. Review of anatomy, evaluation, and treatment of musculoskeletal pelvic floor pain in women. PM R. 2009;1(4):346–58.\nBarber MD, et al. Innervation of the female levator ani muscles. Am J Obstet Gynecol. 2002;187(1):64–71.\nSiegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.\nHuffman LB, et al. Maintaining sexual health throughout gynecologic cancer survivorship: a comprehensive review and clinical guide. Gynecol Oncol. 2016;140(2):359–68.\nBoggess JF, et al. A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy. Am J Obstet Gynecol. 2008;199(4):360 e1–9.\nL Aerts PE, J Verhaeghe W, Poppe I, Vergote FA. Sexual functioning in women after surgical treatment for endometrial cancer: a prospective controlled study. J Sex Med. 2015;12(1):198–209.\nKatz A, et al. Early development of vaginal shortening during radiation therapy for endometrial or cervical cancer. Int J Gynecol Cancer. 2001;11(3):234–5.\nBrand AH, Bull CA, Cakir B. Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix. Int J Gynecol Cancer. 2006;16(1):288–93.\nJemal A, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.\nJackson KS, Naik R. Pelvic floor dysfunction and radical hysterectomy. Int J Gynecol Cancer. 2006;16:354–63.\nPark SY, et al. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer. 2007;110(12):2716–25.\nGreimel ER, et al. Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study. Psychooncology. 2009;18(5):476–82.\nPieterse QD, et al. An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer. Int J Gynecol Cancer. 2006;16(3):1119–29.\nCollaboration, C.f.C.C.M.-A. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008;26(35):5802–12.\nGreen JA, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix (review). Cochrane Database Syst Rev. 2005;3:CD002225.\nKirwan JM, et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol. 2003;68:217–26.\nBruner DW, et al. Measurement of vaginal length: reliability of the vaginal sound—a gynecologic oncology group study. Int J Gynecol Cancer. 2006;16(5):1749–55.\nNoronha AF, et al. Treatments for invasive carcinoma of the cervix: what are their impacts on the pelvic floor functions? Int Braz J Urol. 2013;39(1):46–54.\nBuković D, et al. Sexual functioning and body image of patients treated for ovarian Cancer. Sex Disabil. 2008;26(2):63–73.\nHindocha A, Beere L, Dias S, Watson A, Ahmad G. Adhesion prevention agents for gynaecological surgery: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015. CD 011254.\nHampl M, et al. New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol. 2008;109(3):340–5.\nStehman FB, Look KY. Carcinoma of the vulva. Obstet Gynecol. 2006;107(3):719–33.\nGaarenstroom KN, et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer. 2003;13(4):522–7.\nBarlow EL, et al. Sexuality and body image following treatment for early-stage vulvar cancer: a qualitative study. J Adv Nurs. 2014;70(8):1856–66.\nAlbertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005;293(17):2095–101.\nLu-Yao GL, et al. Outcomes of localized prostate cancer following conservative management. JAMA. 2009;302(11):1202–9.\nThor M, et al. Radiation dose to the penile structures and patient-reported sexual dysfunction in long-term prostate cancer survivors. J Sex Med. 2015;12(12):2388–97.\nBudaus L, et al. Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature. Eur Urol. 2012;61:112–27.\nPotosky AL, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst. 2004;96(18):1358–67.\nCarter J, Goldfrank D, Schover LR. Simple strategies for vaginal health promotion in cancer survivors. J Sex Med. 2011;8(2):549–59.\nStones RW, Mountfield J. Interventions for treating chronic pelvic pain in women. Cochrane Database Syst Rev. 2000. CD000387.\nJohnson N, Miles TP, Cornes P. Dilating the vagina to prevent damage from radiotherapy: systematic review of the literature. BJOG. 2010;117(5):522–31.\nBygdeman M, Swahn ML. Replens versus Dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas. 1996;23(3):259–63.\nChen J, et al. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial. J Sex Med. 2013;10(6):1575–84.\nSuckling JA, et al. Local estrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2006. CD001500.\nWriting Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the women’s health initiative randomized controlled trial. JAMA. 2002;288(3):321–33.\nLee RB, Burke TW, Park RC. Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol. 1990;36:189–91.\nBarakat RR, et al. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a gynecologic oncology group study. J Clin Oncol. 2006;24(4):587–92.\nGoetsch MF, Lim JYC, B A. A practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2015;33(30):3394–400.\nGoldfinger C, et al. A prospective study of pelvic floor physical therapy: pain and psychosexual outcomes in provoked vestibulodynia. J Sex Med. 2009;6(7):1955–68.\nPortenoy RK. Cancer pain. Epidemiology and syndromes. Cancer. 1989;63(11 Suppl):2298–307.\nSchug SA, Zech D, Dorr U. Cancer pain management according to WHO analgesic guidelines. J Pain Symptom Manage. 1990;5(1):27–32.\nCaraceni A, Portenoy RK. Pain management in patients with pancreatic carcinoma. Cancer. 1996;78(3 Suppl):639–53.\nCarrico DJ, Peters KM. Vaginal diazepam use with urogenital pain/pelvic floor dysfunction: serum diazepam levels and efficacy data. Urol Nurs. 2011;31(5):279–84. 299\nMalec-Milewska M, et al. Neurolytic block of ganglion of Walther for the management of chronic pelvic pain. Wideochir Inne Tech Maloinwazyjne. 2014;9(3):458–62.\nde Leon-Casasola OA. Critical evaluation of chemical neurolysis of the sympathetic axis for cancer pain. Cancer Control. 2000;7(2):142–8.\nMichalek P, Dutka J. Computed tomography-guided anterior approach to the superior hypogastric plexus for noncancer pelvic pain: a report of two cases. Clin J Pain. 2005;21(6):553–6.\nGhoneim AA, Mansour SM. Comparative study between computed tomography guided superior hypogastric plexus block and the classic posterior approach: a prospective randomized study. Saudi J Anaesth. 2014;8(3):378–83.\nMishra S, Bhatnagar S, Rana SP, Khurana D, Thulkar S. Efficacy of the anterior ultrasound-guided superior hypogastric plexus neurolysis in pelvic cancer pain in advanced gynecological cancer patients. Pain Med. 2013;14:837–42.\nMoldwin RM, Fariello JY. Myofascial trigger points of the pelvic floor: associations with urological pain syndromes and treatment strategies including injection therapy. Curr Urol Rep. 2013;14(5):409–17.\nAbbott JA, et al. Botulinum toxin type a for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol. 2006;108(4):915–23.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 2019 Springer Nature Switzerland AG\nAbout this chapter\nCite this chapter\nHwang, S., Clark, M. (2019). Cancer-Related Pelvic Pain. In: Gulati, A., Puttanniah, V., Bruel, B., Rosenberg, W., Hung, J. (eds) Essentials of Interventional Cancer Pain Management. Springer, Cham. https://doi.org/10.1007/978-3-319-99684-4_42\nDownload citation\nDOI: https://doi.org/10.1007/978-3-319-99684-4_42\nPublished:\nPublisher Name: Springer, Cham\nPrint ISBN: 978-3-319-99682-0\nOnline ISBN: 978-3-319-99684-4\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}